Related Experiment Video
Updated: Jan 22, 2026

Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs
Published on: June 23, 2022
Experimental evidences that P21 protein controls Trypanosoma cruzi replication and modulates the pathogenesis of
Thaise L Teixeira1, Patrícia Castilhos1, Cassiano C Rodrigues1
1Laboratório de Tripanosomatídeos, Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Rua Piauí, Bloco 2B Sala 200 Campus Umuarama, 38400-902, Uberlândia, MG, Brazil.
Abstract:
P21 is a protein secreted by Trypanosoma cruzi (T. cruzi). Previous studies have shown a spectrum of biological activities performed by P21 such as induction of phagocytosis, leukocyte chemotaxis and inhibition of angiogenesis. However, the activity of P21 in T. cruzi infection remains unknown. Here, we reported the role of P21 in mice harboring late T. cruzi infection. Treatment with recombinant P21 protein (rP21) reduced parasite load and angiogenesis, and induced fibrosis in the cardiac tissue of infected mice. In addition, rP21 reduced the growth of epimastigotes, inhibited intracellular replication of amastigotes and modulated the parasite cell cycle. Our data suggest that P21 controls parasite replication in the host, supporting the survival of both parasite and host.
Insights
The Trypanosoma cruzi (T. cruzi) protein P21, when administered as recombinant P21 (rP21), reduced parasite load and cardiac fibrosis in infected mice. P21 also inhibited parasite growth and replication, suggesting a role in host-parasite survival.
Area of Science:
- Parasitology
- Immunology
- Molecular Biology
Background:
- P21 is a Trypanosoma cruzi (T. cruzi) secreted protein with known roles in phagocytosis, leukocyte chemotaxis, and angiogenesis inhibition.
- The specific function of P21 during active T. cruzi infection has not been previously elucidated.
Purpose of the Study:
- To investigate the role and therapeutic potential of P21 in a murine model of late-stage T. cruzi infection.
Main Methods:
- Treatment of infected mice with recombinant P21 (rP21).
- Assessment of parasite load, cardiac tissue fibrosis, and angiogenesis.
- In vitro evaluation of rP21 effects on T. cruzi epimastigote growth and amastigote replication.
- Analysis of parasite cell cycle modulation by rP21.
Main Results:
- rP21 treatment significantly reduced parasite burden in infected mice.
- Cardiac angiogenesis was decreased, while fibrosis was induced by rP21.
- rP21 inhibited the in vitro growth of epimastigotes and intracellular replication of amastigotes.
- rP21 modulated the cell cycle of T. cruzi parasites.
Conclusions:
- P21 plays a crucial role in controlling T. cruzi replication within the host.
- rP21 demonstrates therapeutic potential for Chagas disease by reducing parasite load and modulating host tissue response.
- P21 appears to support the survival of both the parasite and the host during infection.
Related Concept Videos
The Evidence for Evolution
Chromosome Replication
Replication in Prokaryotes
The DNA Replication Fork
DNA Replication
Replication in Prokaryotes
DNA replication...
Replication in Eukaryotes

